Unlock instant, AI-driven research and patent intelligence for your innovation.
Preparation method of secnidazole and dexamethasone oral sustained-release medicine membrane
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of secnidazole and dexamethasone, applied in the field of medicine, can solve problems such as poor clinical curative effect, and achieve the effects of low manufacturing cost, exact curative effect and stable quality
Inactive Publication Date: 2016-04-13
张庆峰
View PDF1 Cites 2 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0005] At present, there are more and more patients with oral ulcers, periodontitis, and pericoronitis. Although there are many kinds of drugs for the treatment of oral ulcers, periodontitis, and pericoronitis, the clinical efficacy is not good and cannot meet the needs of patients. Need a kind of medicine with good curative effect for treating stomatitis
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0022] A kind of preparation method of secnidazole, dexamethasone oral sustained-release drug film, comprises the following steps:
[0023] 1) Weigh 1 part of secnidazole, 0.2 part of dexamethasone acetate, 3 parts of chitosan, 1 part of gelatin, 6 parts of glycerin, 10 parts of ethanol, 10 parts of dilute acetic acid, and about 80 parts of water for injection according to parts by weight ;
[0025] 3) Add glycerin and gelatin to the above-mentioned transparent colloidal solution, add water for injection, stir in a water bath at 30-40°C to fully swell and dissolve, and obtain a blank drug film colloidal solution;
[0027] 5) Put the mixed solution in a water bath at 30-40°C, ke...
Embodiment 2
[0032] A kind of preparation method of secnidazole, dexamethasone oral sustained-release drug film, comprises the following steps:
[0033] 1) Weigh 1 part of secnidazole, 0.3 part of dexamethasone acetate, 4 parts of chitosan, 1.2 parts of gelatin, 6 parts of glycerin, 9 parts of ethanol, 10 parts of dilute acetic acid, and about 90 parts of water for injection according to parts by weight ;
[0034] 2) Add chitosan to water for injection, add dilute acetic acid dropwise, and stir to dissolve into a transparent colloidal solution;
[0035] 3) Add glycerin and gelatin to the above-mentioned transparent colloidal solution, add water for injection, stir in a water bath at 30-40°C to fully swell and dissolve, and obtain a blank drug film colloidal solution;
[0036] 4) add secnidazole and dexamethasone acetate to ethanol, stir to make secnidazole and dexamethasone acetate dissolve completely, form ethanol solution;
[0037] 5) Put the mixed solution in a water bath at 30-40°C, ...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention discloses a secnidazole and dexamethasone oral sustained-release medicine membrane. The secnidazole and dexamethasone oral sustained-release medicine membrane is prepared from the following raw materials in parts by weight: 0.5-1 part of secnidazole, 0.1-0.3 part of dexamethasone acetate, 2-4 parts of chitosan, 1-1.5 parts of gelatin, 4-6 parts of glycerol, 9-10 parts of ethanol, 10 parts of dilute acetic acid and about 80-100 parts of water for injection. The invention also discloses a preparation method of the secnidazole and dexamethasone oral sustained-release medicine membrane. The preparation method has the following advantages: the process is simple, the prepared secnidazole and dexamethasone oral sustained-release medicine membrane is stable in quality, convenient to use, definite in curative effect and low in manufacturing cost, has a good curative effect on treating oral inflammation and therefore is worthy of popularization.
Description
Technical field: [0001] The invention relates to a preparation method of an oral sustained-release drug film of secnidazole and dexamethasone, which belongs to the technical field of medicine. Background technique: [0002] Oral ulcer, commonly known as "oral sore", is a common ulcerative injury disease that occurs in the oral mucosa. It is more common in the inner lip, tongue, tongue belly, buccal mucosa, vestibular groove, soft palate and other parts. The mucosa in these parts lacks stratum corneum. or poor keratosis. Tongue ulcers refer to oral ulcers that occur on the tongue and the abdomen of the tongue. When oral ulcersattack, the pain is severe, and the local burning pain is obvious. In severe cases, it will also affect eating and speaking, causing great inconvenience to daily life; Symptoms such as swollen lymph nodes. [0003] Periodontitis is the most common disease in the oral cavity, and the prevalence rate among adults is as high as 90%. Periodontal disease ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.